Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Regulatory functions of innate-like B cells

Abstract

Innate-like B cells (ILBs) are heterogeneous populations of unconventional B cells with innate sensing and responding properties. ILBs in mice are composed of B1 cells, marginal zone (MZ) B cells and other related B cells. ILBs maintain natural IgM levels at steady state, and after innate activation, they can rapidly acquire immune regulatory activities through the secretion of natural IgM and IL-10. Thus, ILBs constitute an important source of IL-10-producing regulatory B cells (Bregs), which have been shown to play critical roles in autoimmunity, inflammation and infection. The present review highlights the latest advances in the field of ILBs and focuses on their regulatory functions. Understanding the regulatory activities of ILBs and their underlying mechanisms could open new avenues in manipulating their functions in inflammatory, infectious and other relevant diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Bendelac A, Bonneville M, Kearney JF . Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001; 1: 177–186.

    CAS  PubMed  Google Scholar 

  2. Kearney JF . Innate-like B cells. Springer Semin Immun 2005; 26: 377–383.

    Google Scholar 

  3. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765.

    CAS  PubMed  Google Scholar 

  4. Kaveri SV, Silverman GJ, Bayry J . Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 2012; 188: 939–945.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA . Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999; 96: 2250–2255.

    CAS  PubMed  Google Scholar 

  6. van Oudenaren A, Haaijman JJ, Benner R . Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic and euthymic mice as a function of age and immune status. Immunology 1984; 51: 735–742.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Choi YS, Dieter JA, Rothaeusler K, Luo Z, Baumgarth N . B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol 2012; 42: 120–129.

    CAS  PubMed  Google Scholar 

  8. Martins G, Calame K . Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 2008; 26: 133–169.

    CAS  PubMed  Google Scholar 

  9. Tumang JR, Frances R, Yeo SG, Rothstein TL . Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol 2005; 174: 3173–3177.

    CAS  PubMed  Google Scholar 

  10. Gunn KE, Brewer JW . Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J Immunol 2006; 177: 3791–3798.

    CAS  PubMed  Google Scholar 

  11. Fairfax KA, Corcoran LM, Pridans C, Huntington ND, Kallies A, Nutt SL et al. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene. J Immunol 2007; 178: 4104–4111.

    CAS  PubMed  Google Scholar 

  12. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T . TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 2007; 178: 7779–7786.

    CAS  PubMed  Google Scholar 

  13. Ha SA, Tsuji M, Suzuki K, Meek B, Yasuda N, Kaisho T et al. Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 2006; 203: 2541–2550.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Yang Y, Tung JW, Ghosn EE, Herzenberg LA . Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci USA 2007; 104: 4542–4546.

    CAS  PubMed  Google Scholar 

  15. Martin F, Oliver AM, Kearney JF . Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001; 14: 617–629.

    CAS  PubMed  Google Scholar 

  16. Shimomura Y, Mizoguchi E, Sugimoto K, Kibe R, Benno Y, Mizoguchi A et al. Regulatory role of B-1 B cells in chronic colitis. Int Immunol 2008; 20: 729–737.

    CAS  PubMed  Google Scholar 

  17. Stoehr AD, Schoen CT, Mertes MM, Eiglmeier S, Holecska V, Lorenz AK et al. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity. J Immunol 2011; 187: 2953–2965.

    CAS  PubMed  Google Scholar 

  18. Savitsky D, Calame K . B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J Exp Med 2006; 203: 2305–2314.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Calame K . Activation-dependent induction of Blimp-1. Curr Opin Immunol 2008; 20: 259–264.

    CAS  PubMed  Google Scholar 

  20. Meyer-Bahlburg A, Bandaranayake AD, Andrews SF, Rawlings DJ . Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol 2009; 182: 4065–4075.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Flach H, Rosenbaum M, Duchniewicz M, Kim S, Zhang SL, Cahalan MD et al. Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells. Immunity 2010; 33: 723–735.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrancois L et al. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 2007; 26: 215–226.

    PubMed  PubMed Central  Google Scholar 

  23. Coe H, Michalak M . ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase. Int J Biochem Cell B 2010; 42: 796–799.

    CAS  Google Scholar 

  24. Katz SI, Parker D, Turk JL . B-cell suppression of delayed hypersensitivity reactions. Nature 1974; 251: 550–551.

    CAS  PubMed  Google Scholar 

  25. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr . Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996; 184: 2271–2278.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM . B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944–950.

    CAS  PubMed  Google Scholar 

  27. Mauri C, Gray D, Mushtaq N, Londei M . Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003; 197: 489–501.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK . Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219–230.

    CAS  PubMed  Google Scholar 

  29. Mizoguchi A, Bhan AK . A case for regulatory B cells. J Immunol 2006; 176: 705–710.

    CAS  PubMed  Google Scholar 

  30. DiLillo DJ, Matsushita T, Tedder TF . B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 2010; 1183: 38–57.

    CAS  PubMed  Google Scholar 

  31. Mauri C, Bosma A . Immune regulatory function of B cells. Annu Rev Immunol 2012; 30: 221–241.

    CAS  PubMed  Google Scholar 

  32. Matsumoto M, Fujii Y, Baba A, Hikida M, Kurosaki T, Baba Y . The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 2011; 34: 703–714.

    CAS  PubMed  Google Scholar 

  33. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009; 182: 3492–3502.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M . Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711–717.

    CAS  PubMed  Google Scholar 

  35. Sun CM, Deriaud E, Leclerc C, Lo-Man R . Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005; 22: 467–477.

    CAS  PubMed  Google Scholar 

  36. Lenert P, Brummel R, Field EH, Ashman RF . TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005; 25: 29–40.

    CAS  PubMed  Google Scholar 

  37. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868–7878.

    CAS  PubMed  Google Scholar 

  38. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF . A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28: 639–650.

    CAS  PubMed  Google Scholar 

  39. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderon Gomez E, Sweenie CH et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180: 4763–4773.

    CAS  PubMed  Google Scholar 

  40. Matsushita T, Horikawa M, Iwata Y, Tedder TF . Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010; 185: 2240–2252.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186: 5569–5579.

    CAS  PubMed  Google Scholar 

  42. Yang M, Sun L, Wang S, Ko KH, Xu H, Zheng BJ et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 2010; 184: 3321–3325.

    CAS  PubMed  Google Scholar 

  43. Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z et al. IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol 2012; 180: 2375–2385.

    CAS  PubMed  Google Scholar 

  44. Zhang X, Deriaud E, Jiao X, Braun D, Leclerc C, Lo-Man R . Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells. J Exp Med 2007; 204: 1107–1118.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Walker WE, Goldstein DR . Neonatal B cells suppress innate Toll-like receptor immune responses and modulate alloimmunity. J Immunol 2007; 179: 1700–1710.

    CAS  PubMed  Google Scholar 

  46. Watanabe R, Fujimoto M, Ishiura N, Kuwano Y, Nakashima H, Yazawa N et al. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007; 171: 560–570.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Nakashima H, Hamaguchi Y, Watanabe R, Ishiura N, Kuwano Y, Okochi H et al. CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010; 184: 4637–4645.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Velupillai P, Harn DA . Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 1994; 91: 18–22.

    CAS  PubMed  Google Scholar 

  49. Velupillai P, Secor WE, Horauf AM, Harn DA . B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158: 338–344.

    CAS  PubMed  Google Scholar 

  50. Mangan NE, Fallon RE, Smith P, van Rooijen N, McKenzie AN, Fallon PG . Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol 2004; 173: 6346–6356.

    CAS  PubMed  Google Scholar 

  51. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG . Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immun 2010; 125: 1114–1124.e8.

    CAS  PubMed  Google Scholar 

  52. Ronet C, Hauyon-La Torre Y, Revaz-Breton M, Mastelic B, Tacchini-Cottier F, Louis J et al. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 2010; 184: 886–894.

    CAS  PubMed  Google Scholar 

  53. Bankoti R, Gupta K, Levchenko A, Stager S . Marginal zone B cells regulate antigen-specific T cell responses during infection. J Immunol 2012; 188: 3961–3971.

    CAS  PubMed  Google Scholar 

  54. Neves P, Lampropoulou V, Calderon-Gomez E, Roch T, Stervbo U, Shen P et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 2010; 33: 777–790.

    CAS  PubMed  Google Scholar 

  55. Lee CC, Kung JT . Marginal zone B cell is a major source of IL-10 in Listeria monocytogenes susceptibility. J Immunol 2012; 189: 3319–3327.

    CAS  PubMed  Google Scholar 

  56. Velupillai P, Garcea RL, Benjamin TL . Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and -resistant mice. J Immunol 2006; 176: 1148–1153.

    CAS  PubMed  Google Scholar 

  57. Madan R, Demircik F, Surianarayanan S, Allen JL, Divanovic S, Trompette A et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J Immunol 2009; 183: 2312–2320.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Srivastava B, Quinn WJ 3rd, Hazard K, Erikson J, Allman D . Characterization of marginal zone B cell precursors. J Exp Med 2005; 202: 1225–1234.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Hao Y, O'Neill P, Naradikian MS, Scholz JL, Cancro MP . A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 2011; 118: 1294–1304.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. de Andres B, Prado C, Palacios B, Alia M, Jagtap S, Serrano N et al. Dynamics of the Splenic Innate-like CD19+CD45Rlo cell population from adult mice in homeostatic and activated conditions. J Immunol 2012; 189: 2300–2308.

    CAS  PubMed  Google Scholar 

  61. Qian L, Qian C, Chen Y, Bai Y, Bao Y, Lu L et al. Regulatory dendritic cells program B cells to differentiate into CD19hiFcgammaIIbhi regulatory B cells through IFN-beta and CD40L. Blood 2012; 120: 581–591.

    CAS  PubMed  Google Scholar 

  62. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL . Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 167: 1081–1089.

    CAS  PubMed  Google Scholar 

  63. Parekh VV, Prasad DV, Banerjee PP, Joshi BN, Kumar A, Mishra GC . B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol 2003; 170: 5897–5911.

    CAS  PubMed  Google Scholar 

  64. Lundy SK, Boros DL . Fas ligand-expressing B-1a lymphocytes mediate CD4+-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 2002; 70: 812–819.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME et al. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104: 3647–3654.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Tangye SG, Good KL . Human IgM+CD27+ B cells: memory B cells or “memory” B cells? J Immunol 2007; 179: 13–19.

    CAS  PubMed  Google Scholar 

  67. Good KL, Avery DT, Tangye SG . Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 2009; 182: 890–901.

    CAS  PubMed  Google Scholar 

  68. Davey AM, Pierce SK . Intrinsic differences in the initiation of B cell receptor signaling favor responses of human IgG+ memory B cells over IgM+ naive B cells. J Immunol 2012; 188: 3332–3341.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE . Identification and characterization of circulating human transitional B cells. Blood 2005; 105: 4390–4398.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Griffin DO, Holodick NE, Rothstein TL . Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 2011; 208: 67–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Griffin DO, Rothstein TL . A small CD11b+ human B1 cell subpopulation stimulates T cells and is expanded in lupus. J Exp Med 2011; 208: 2591–2598.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Descatoire M, Weill JC, Reynaud CA, Weller S . A human equivalent of mouse B-1 cells? J Exp Med 2011; 208: 2563–2564.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Perez-Andres M, Grosserichter-Wagener C, Teodosio C, van Dongen JJ, Orfao A, van Zelm MC . The nature of circulating CD27+CD43+ B cells. J Exp Med 2011; 208: 2565–2566; author reply 2566–2569.

    PubMed  PubMed Central  Google Scholar 

  74. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007; 178: 6092–6099.

    CAS  PubMed  Google Scholar 

  75. Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010; 32: 129–140.

    CAS  PubMed  Google Scholar 

  76. Correale J, Farez M, Razzitte G . Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008; 64: 187–199.

    PubMed  Google Scholar 

  77. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010; 120: 1836–1847.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189: 3925–3935

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Bernasconi NL, Onai N, Lanzavecchia A . A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101: 4500–4504.

    CAS  PubMed  Google Scholar 

  80. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117: 530–541.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Miles K, Heaney J, Sibinska Z, Salter D, Savill J, Gray D et al. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci USA 2012; 109: 887–892.

    CAS  PubMed  Google Scholar 

  82. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A et al. IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro. Eur J Immunol 2010; 40: 2686–2691.

    CAS  PubMed  Google Scholar 

  83. Hansell CA, Schiering C, Kinstrie R, Ford L, Bordon Y, McInnes IB et al. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 2011; 117: 5413–5424.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; 121: 3645–3656.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from National Natural Science Foundation of China (31270961) and Shanghai Science and Technology Development Funds (12QA1403600). The author would like to thank Mr Yiyuan Fang for his help with figure preparation and Mr Brian Mozeleski for his critical reading.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoming Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, X. Regulatory functions of innate-like B cells. Cell Mol Immunol 10, 113–121 (2013). https://doi.org/10.1038/cmi.2012.63

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2012.63

Keywords

This article is cited by

Search

Quick links